MIM
EXAS

Macroview Investment Management’s Exact Sciences EXAS Stock Holding History

Macroview Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36
Closed -$2.45K – 239
2024
Q3 		$2.45K Hold
36
– – ﹤0.01% 458
2024
Q2 		$1.52K Hold
36
– – ﹤0.01% 503
2024
Q1 		$2.49K Sell
36
-102
-74% -$6.45K ﹤0.01% 510
2023
Q4 		$10.2K Sell
138
-12
-8% -$787 0.01% 255
2023
Q3 		$10.2K Buy
150
+26
+21% +$2.21K 0.01% 257
2023
Q2 		$11.6K Sell
124
-37
-23% -$2.89K 0.02% 228
2023
Q1 		$10.9K Buy
+161
New +$10.3K 0.02% 237

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macroview Investment Management's EXAS Position: Q4 2024 in Review

Macroview Investment Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 36 shares — an estimated $2.45K sold.

Macroview Investment Management first reported a position in EXAS in Q1 2023 and held it in 7 quarters. The position peaked at $11.6K in Q2 2023. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Macroview Investment Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 36 Exact Sciences shares in Q4 2024, an estimated $2.45K.
  • Macroview Investment Management first reported a position in Exact Sciences in Q1 2023 and held it in 7 quarters.
  • Macroview Investment Management's Exact Sciences position peaked at $11.6K in Q2 2023.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.